TheDrumGuy
Member
- Joined
- Sep 27, 2017
- Messages
- 119
That's overly-simplified. Pharmacokinetics takes into account testosterone exposure and receptor density.
Right, it depends on testosterone concentration and receptor concentration.
Bigger tissue should have more absolute receptors, and thus higher relative density compared to slightly more testosterone molecules from a bigger person. Thus, less androgen receptor dimierization/signaling.
Bigger tissue also has more volume. Twice the volume, twice the receptors; density is receptors divided by volume, and the 2's cancel out when you calculate density.